Albumin (human) 25%
آلبومین انسانی ۲۵٪
🩸 Blood And Blood Forming OrgansPlasma colloid
Market / country: 🇺🇸 USA
Albuminex (US)
🧮 Dose calculator
Shock (septic, cardiogenic, acute hypotension) — ICU · Regimen source: FDA Albuminex 25% · 2.1
- • Acute liver failure: 12–25 g. Usual rate 1–2 mL/min. Never dilute with sterile water (haemolysis). FDA Albuminex 25% · 2.1FDA Albuminex 25% · 2.3
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to albumin; severe anaemia or cardiac failure with normal or increased intravascular volume. FDA Albuminex 25% · 4
Warnings
- • Hypervolaemia and pulmonary oedema (match rate to haemodynamics); hypersensitivity. FDA Albuminex 25% · 5
- • Human plasma-derived — theoretical risk of transmitting infectious agents. FDA Albuminex 25% · 5.6
Formulations
- 25% (25 g/100 mL; 12.5 g/50 mL) — injection 🇺🇸 USA FDA Albuminex 25% · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Albuminex 25% · 8.1
“Risk Summary There are no data with ALBUMINEX 25% use in pregnant women to inform on drug-associated risk.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Albuminex 25% · 8.2
“Risk Summary There is no information regarding the presence of ALBUMINEX 25% in human milk, the effects on the breast-fed infant, or the effects on milk production.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Albuminex 25% · 8.4
“No human or animal data.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Albuminex 25% · 8.5
“No human or animal data.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)BLA125644
- DailyMed (FDA label)FDA Albuminex 25%
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDB05AA01
- Darooyab (Iran)Albumin
🇮🇷 Registered in Iran Darooyab · G-1375/Albumin
Dosage forms with Iranian generic codes, per Darooyab.
- 06888 · ALBUMIN (HUMAN) 20% 100ML INF · محلول انفوزیون آلبومین انسانی ۲۰ درصد ۱۰۰ میلیلیتر
- 00027 · ALBUMIN (HUMAN) 20% 50ML VIAL · ویال آلبومین انسانی ۲۰ درصد ۵۰ میلیلیتر
- 00028 · ALBUMIN (HUMAN) 5% 100ML VIAL · ویال آلبومین انسانی ۵ درصد ۱۰۰ میلیلیتر
- 12520 · ALBUMIN (HUMAN) 5% 500ML VIAL · ویال آلبومین انسانی ۵ درصد ۵۰۰ میلیلیتر
- 11504 · ALBUMIN 5% 250ML VIAL · ویال آلبومین ۵ درصد ۲۵۰ میلیلیتر
- 00029 · ALBUMIN SP 15% · آلبومین SP، ۱۵ درصد
- 50954 · ALBUMIN (HUMAN) INJECTION, SOLUTION PARENTERAL 20 % 250 mL · محلول تزریقی آلبومین (انسانی) ۲۰ درصد ۲۵۰ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Albuminex 25% · 3FDA Albuminex 25% · 2.1FDA Albuminex 25% · 2.3FDA Albuminex 25% · 4FDA Albuminex 25% · 5FDA Albuminex 25% · 5.6FDA Albuminex 25% · SPL approval / marketing categoryFDA Albuminex 25% · 8.1FDA Albuminex 25% · 8.2FDA Albuminex 25% · 8.4FDA Albuminex 25% · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1375/Albumin
- Clinical review⚠ Unverified